EGFR and lung cancer: We used negative control cell lines, which included a normal immortalized human bronchial epithelial cell line (Beas‐2B), a cell line expressing constitutively active EGFR (HCC827) and a lung cancer cell line with no known drivers (H2126; mutations and copy number alterations for all cancer cell lines are included in Dataset EV1).